UCB SA has announced a new partnership with Domino Data Lab to modernize its Statistical Computing Environment $(SCE.UK)$ and advance the development of innovative therapies for severe diseases. This collaboration aims to enhance UCB's research capabilities by integrating diverse analytical tools like SAS, R, and Python within a cloud-enabled framework, leveraging Domino's cloud technologies and open-source support. The partnership will also focus on fostering open-source principles and establishing global standards for efficient and compliant statistical environments, contributing to initiatives like PHUSE and the SCE Coalition. UCB's broader scientific innovation strategy aligns with this effort to accelerate clinical development and maintain compliance with industry standards such as GxP, FDA 21 CFR Part 11, and GDPR.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.